Kurma Partners is a major player in the funding of healthcare and biotechnology across Europe. With a strong network of partners, including the best European academic research players, Kurma Partners is dedicated to transforming disruptive scientific discoveries into cutting-edge medicines and medical devices. The company's unique approach involves early involvement with research teams to validate discoveries and collaborate with industry experts and experienced entrepreneurs to create high-tech companies.

Beyond founding new companies, Kurma Partners is also committed to supporting the development of existing early stage companies and has contributed to the financing of over 40 companies, many of which have become leaders in their respective sectors. The company operates with a focus on sustainable development, adhering to established ESG practices and implementing strict inclusion and exclusion criteria related to medical bioethics. As a proactive contributor to addressing unmet medical needs, Kurma Partners is aligned with the United Nations Sustainable Development Goal No.

3. Their impactful work and commitment to ethical policies have established them as a reputable and influential force in the healthcare and biotechnology investment landscape